Name : MR.

ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : SERUM1 Collected : 12/06/2025, 11:35 AM
Sample ID : 245322921 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:21 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Lipid Profile
Cholesterol - Total 175 mg/dL <200 : Desirable
(Method: Cholesterol Oxidase, Esterase, peroxidase)
200-239 : Borderline risk
>240 : High risk
Cholesterol - HDL 60.5 mg/dL > 55 : No Risk
(Method: Enzymatic Colorimetric)
35 - 55 : Moderate Risk
< 35 High Risk
Cholesterol - LDL 84.90 mg/dL < 100 : Normal
(Method: Calculated)
100 - 129 : Desirable
130 – 159 : Borderline-High
160 – 189 : High
> 190 : Very High
Cholesterol VLDL 29.60 mg/dL 7 - 40
(Method: Calculated)
Triglycerides 148 mg/dL < 150 :Normal
(Method: Lipase / Glycerol Kinase)
150–199 :Borderline-High
200–499 :High
> 500 :Very High
Cholesterol - Non-HDL 114.50 mg/dL < 130 mg/dl: Desirable
(Method: Calculated)
Total cholesterol/HDL 2.89 Ratio 0 - 5.0
(Method: Calculated)
LDL / HDL 1.40 Ratio 0 - 3.5
(Method: Calculated)
HDL / LDL 0.71 Ratio 0 - 3.5
(Method: Calculated)
Interpretation:
• For non-fasting samples, the biological reference interval remains the same for all parameters, except of triglyceride as cholesterol (HDL, LDL, total), which changes

only by a small amount in the non-fasting state; the recommended desired value for triglyceride is <175 mg/dl. In the non-sting state, individuals with a non-fasting

triglyceride level >200 mg/dl, are recommended to perform a follow-up fasting lipid panel in 2 to 4 weeks.

• As per the consensus of the Lipid Association of India, non-HDL cholesterol and LDL cholesterol can be used as targets to monitor the effectiveness of lipid-lowering

therapy.

Associated tests: Apolipoproteins A1, Apolipoproteins B, Apolipoprotein B/A1 Ratio, Lipoprotein(a)

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 1 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : SERUM1 Collected : 12/06/2025, 11:35 AM
Sample ID : 245322921 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:59 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Liver Function Profile

Bilirubin Total 0.8 mg/dL Upto 1.2
(Method: Diazo Method)
Bilirubin Direct 0.3 mg/dL 0 - 0.30
(Method: Diazo method)
Bilirubin Indirect 0.50 mg/dL 0 - 1.0
(Method: Calculated)
Alkaline Phosphatase (ALP) 120 U/L 43 - 115
(Method: PNPP, AMP Buffer)
Alanine Transaminase (ALT/SGPT) 149 U/L Upto 50
(Method: UV without pyridoxal -5- phosphate)
Aspartate Aminotransferase(AST/SGOT) 131 U/L Upto 50
(Method: IFCC Without Pyridoxal Phosphate)
Y- Glutamyl Transferase (GGT) 85 U/L 10 - 71
(Method: glutamyl-carboxynitroanilide)
Protein Total 7.7 g/dL 6.6 - 8.7
(Method: Biuret)
Albumin 4.6 g/dL 3.97 - 4.94
(Method: Bromcresol Green)
Globulin 3.10 g/dl 2.5 - 3.5
(Method: Calculated)
Albumin/Globulin 1.48 Ratio 1.0 - 2.1
(Method: Calculated)
AST / ALT Ratio 0.88 Ratio -
(Method: Calculated)
Interpretation:
LFT results reflect different aspects of the health of the liver, i.e., hepatocyte integrity(AST & ALT),synthesis and secretion of bile (Bilirubin ,ALP),cholestasis (ALP,GGT),protein synthesis (Albumin).
1. Hepatocellular injury:
• AST-Elevated levels can be seen. However,it is not specific to liver and can be raised in cardiac and skeletal injuries.
• ALT -Elevated levels indicate hepatocellular damage. It is considered to be most specific lab test for hepatocellular injury.
Values also correlate well with increasing BMI.
• Disproportinate increase in AST,ALT compared with ALP.
• Bilirubin may be elevated.
• AST: ALT (ratio) - In case of hepatocellular injury AST : ALT >1
In Alcoholic Liver Disease AST : ALT usually >2
This ratio is also seen to be increased in NAFLD ,Wilsons's disease, Cirrhosis ,but the increase is usually not >2
2. Cholestatic pattern:
• ALP - Disproportinate increase in ALP compared with AST,ALT.
• Bilirubin may be elevated.
• ALP elevation also seen in pregnancy,impacted by age and sex.
• To establish the hepatic origin correlation with GGT helps. If GGT elevated indicates hepatic cause of increased ALP.

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 2 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : SERUM1 Collected : 12/06/2025, 11:35 AM
Sample ID : 245322921 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:22 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Creatinine 0.9 mg/dL 0.70 - 1.20

(Method: Jaffe Kinetic)
Urea 22 mg/dL 16.6 - 48.5
(Method: Urease)
Blood Urea Nitrogen (BUN) 10.28 mg/dL 6 - 20
(Method: Calculated)
Blood Urea Nitrogen (BUN)/Creatinine 11.42 Ratio 6 - 22
(Method: Calculated)
Sodium 140 mmol/L 135 - 145
(Method: ISE)
Potassium 5.45 mmol/L 3.8 - 5.2
(Method: ISE)
Chloride 87 mmol/L 95 - 105
(Method: ISE)
Uric Acid 2.3 mg/dL 3.4 - 7.0
(Method: Uricase)
Glomerular Filtration Rate (eGFR) 108.70 mL/min 90 - 120 mL/min/1.73 m2
(Method: Calculated)
Interpretation:
Creatinine: Muscles produce creatinine, a waste product, from creatine phosphate, a substance that stores a lot of energy. Unlike urea, the amount of
creatinine generated is constant and mostly depends on muscle mass. Age, gender, race, muscularity, exercise, pregnancy, and several other
physiulogical characteristics can all have an impact on serum creatinine levels. Decreased serum Creatinine is associated with increasing Age and poor
muscle mass, such as muscular atrophy. Both acute and chronic renal disease and blockage are associated with elevated blood creatinine levels.
Creatinine is not an appropriate indicator for identifying kidney disease in its early stages since an increase in blood creatinine is only seen when there is
significant nephron damage.
High Urea, Uric Acid, and Blood Urea Nitrogen (BUN) could indicate poor renal function, in addition to other etiulogies
Sodium:
• Low levels: prulonged vomiting or diarrhea, diminished reabsorption in the kidney, and excessive fluid retention. Pseudo-hyponatremia is a
laboratory artifact. It is usually caused by hypertriglyceridemia, chulestasis (lipoprotein X), and hyperproteinemia (monoclonal gammopathy,
intravenous immunoglobulin [IVIG]). Diluted sampling should also be suspected in such cases and confirmed on a repeat fresh sample if indicated
clinically.
• High levels: excessive fluid loss, high salt intake, and increased kidney reabsorption.
Potassium:
• Low levels: reduced intake of dietary potassium or excessive loss of potassium from the body due to diarrhea, prulonged vomiting, or increased
renal excretion.
• High levels: dehydration or shock, severe burns, hemulysis, diabetic ketoacidosis, and retention of potassium by the kidney. Pseudohyperkalemia,
which may result from a hemulyzed or aged sample, should always be ruled out by doing a repeat electrulyte estimation on a fresh
sample, as clinically indicated.
Chloride:

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 3 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : SERUM1 Collected : 12/06/2025, 11:35 AM
Sample ID : 245322921 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:22 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

• Low levels are noted in reduced dietary intake, prulonged vomiting, and reduced renal reabsorption, as well as some forms of acidosis and alkalosis.
• High levels are found in dehydration, kidney failure, some forms of acidosis, high dietary or parenteral chloride intake, and salicylate poisoning
An estimated glomerular filtration rate (eGFR) test is an indicator of how well kidneys filter waste and toxins from blood.

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 4 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : SERUM1 Collected : 12/06/2025, 11:35 AM
Sample ID : 245322921 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:22 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

IRON PROFILE
Iron 180 µg/dL 33 - 193
(Method: Ferrozine – without Deproteinization)
UIBC 201 µg/dL 155 - 355
(Method: Nitroso-PSAP)
Iron Binding Capacity - Total (TIBC) 381 µg/dL 240 - 450
(Method: Calculated)
Transferrin 259.18 ug/dL 176 - 280
(Method: Calculated)
Transferrin % 47.24 % 20 - 50
(Method: Calculated)

This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 5 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : Urine Collected : 12/06/2025, 11:35 AM
Sample ID : 245322924 Received : 15/06/2025, 02:12 PM
Client Name : 1KABLR360 Reported : 15/06/2025, 07:56 PM

CLINICAL PATHOLOGY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

COMPLETE URINE EXAMINATION(CUE)

PHYSICAL EXAMINATION:
Color Pale yellow --
(Method: Visual Examination)
Appearance Clear --
(Method: Visual Examination)

CHEMICAL EXAMINATION:
Specific gravity 1.010 1.000 - 1.030
(Method: Bromothymol Blue,pKa change)
Reaction (pH) 6.0 5.0 - 9.0
(Method: Bromothymol Blue / Methyl red(Double indicator))
Proteins Negative Negative
(Method: Tetrabromopherol blue (Protein Error of ph
Indicators))
Glucose Positive(+++) Negative
(Method: Glucose Oxidase And Peroxidase Method)
Bilirubin Negative Negative
(Method: Diazonium Salt)
Ketones Negative Negative
(Method: Nitroprusside Reaction)
Blood Negative Negative
(Method: Hemo Peroxidase)
Urobilinogen Normal Normal
(Method: A modified Ehrlich reaction)
Nitrites Negative Negative
(Method: Diazotization reaction)

Microscopic Examination
PUS(WBC) Cells 6-8 0 - 5 /HPF
RBC Absent NIL
Epithelial Cells 3-4 0 - 5/HPF
Casts Absent NIL
Crystals Nil Nil

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 6 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : WB EDTA* Collected : 12/06/2025, 11:35 AM
Sample ID : 245322922 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:21 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Glycosylated Hemoglobin (GHb/HBA1c)

HbA1c 10.7 % Non-Diabetic: <= 5.6
(Method: HPLC)
Pre Diabetic:5.7 - 6.4
Diabetic: >= 6.5
Estimated Average Glucose (eAG) 260.39 mg/dL 70 - 136
Interpretation:
Excellent Control: 6 to 7 %

Fair to Good Control: 7 to 8 %

Unsatisfactory Control: 8 to 10 %

and Poor Control: More than 10%.

Factors Influencing HbA1c Results: Increased levels: Elevated fetal hemoglobin, chronic renal failure, iron deficiency anemia, splenectomy,

heightened serum triglycerides, alcohol consumption, poisoning (Lead, Opiate), and salicylate therapy. Decreased levels: are often associated with

systemic inflammatory diseases and reduced RBC life span, severe iron deficiency & haemolytic anaemia, chronic renal failure, and liver diseases.

Clinical correlation reduced red blood cell lifespan (such as in hemolytic anemia or blood loss), following blood transfusions, during pregnancy, excessive

intake of Vitamin E or Vitamin C, and hemoglobinopathies, For HbF > 25% and homozygous hemoglobinopathy, an alternate platform (Fructosamine) is

recommended for testing of HbA1c.

• HbA1c, also known as glycosylated hemoglobin or glycated hemoglobin, refers to hemoglobin that has glucose molecules attached. It gives an

average of glucose levels in the bloodstream for the preceding 2 to 3 months.

• HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines for the diagnosis of diabetes using a cut-off point of

6.5%.

• For diabetic patients achieving treatment objectives, the HbA1c test should be conducted at least biannually. If treatment objectives are not met or if

a new regimen is initiated, testing once every 3 months is recommended.

• The HbA1c target for non-pregnant adults is generally set at below 7% to prevent microvascular complications.

• In known diabetic patients, the following values can be considered as a tool for monitoring glycemic control.

Associated tests: HOMA IR index, insulin, C-peptide levels.

This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 7 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : SERUM1 Collected : 12/06/2025, 11:35 AM
Sample ID : 245322921 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:22 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Calcium & Phosphorus

Calcium 9.9 mg/dL 8.6 - 10.0
(Method: NM-Bapta complex)
Interpretation:
The diagnosis and monitoring of a wide range of disorders including diseases of bone, kidney, parathyroid gland, or gastrointestinal
tract Calcium levels may also reflect abnormal vitamin D or protein levels. Calcium ions affect the contractility of the heart and the
skeletal musculature, and are essential for the function of the nervous system. In addition, calcium ions play an important role in
blood clotting and bone mineralization.
Hypocalcemia is due to the absence or impaired function of the parathyroid glands or impaired vitamin-D synthesis. Chronic renal
failure is also frequently associated with hypocalcemia due to decreased vitamin-D synthesis as well as hyperphosphatemia and
skeletal resistance to the action of parathyroid hormone (PTH). A characteristic symptom of hypocalcemia is latent or manifest
tetany and osteomalacia.

Phosphorus 2.96 mg/dL 2.5 - 4.5

(Method: Phosphomolybdate - UV)

This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 8 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : SERUM1 Collected : 12/06/2025, 11:35 AM
Sample ID : 245322921 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:38 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Thyroid Profile-II
Triiodothyronine Total (TT3) 139.2 ng/dL 80 - 200
(Method: CLIA)
Triiodothyronine Free (FT3) 3.21 pg/mL 2.3 - 4.2
(Method: CLIA)
Thyroxine - Total (TT4) 5.7 ug/dL 5.1 - 14.1
(Method: CLIA)
Thyroxine - Free (FT4) 1.15 ng/dL 0.80-2.70
(Method: CLIA)
Thyroid Stimulating Hormone (TSH) 2.90 uIU/mL 0.27 - 4.2
(Method: CLIA)
Interpretation:
Important Note:

A TSH value of up to 15 µIU/ml needs clinical correlation or repeat testing with a new sample, as physiological factors can give falsely high TSH.

Transiently Raised TSH can occur due to non-thyroid illnesses like severe infections liver, cardiac, and kidney diseases, burns, surgery, and trauma.

Diurnal Variability: TSH Follows a Diurinal rhythm and is at maximum between 2 am to 4 am and a minimum between 6 to 10 pm. Variation is about

50-206%.

Limitations:
• Patients receiving High Biotin Dose treatment should have a gap of a minimum of 8 hrs, before giving the blood sample.
• Heterophile Antibodies can react in Immunoassay procedures giving erroneous results. The assay is designed to minimize heterophile antibody
interference.
Please Note: FT3 and FT4 Measure the free "unbound" fraction of the T3 and T4 and are considered more sensitive compared to the Total T3 and T4 to

assess thyroid status.

Associated tests: Anti-thyroid Antibodies, USG thyroid, TSH receptor Antibody. Thyroglobulin, Calcitonin.

This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 9 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : WB EDTA* Collected : 12/06/2025, 11:35 AM
Sample ID : 245322922 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:08 PM

HAEMATOLOGY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Complete Blood Count + ESR

Erythrocytes (EDTA, Whole Blood)

Hemoglobin (Hb)* 16.1 g/dL 13.5 - 18.0
(Method: Photometry)
Erythrocyte Count (RBC Count) 4.86 mil/µL 4.7 - 6.0
(Method: Electronic Impedance)
Packed Cell Volume(Hematocrit) 48.1 % 42 - 52
(Method: Calculated)
MCV 99.1 fl 78 - 100
MCH 33.1 pg 27 - 31
MCHC 33.4 g/dL 32.0 - 36.0
RDW 18.3 % 11.5 - 14.0

RBC Morphology
Remarks Normocytic Normochromic

Leucocytes
Total Leucocyte Count (WBC) 3020 cells/Cumm 4000 - 10000
Neutrophils 51 % 40 - 80
Lymphocytes 41 % 20 - 40
Eosinophils 6 % 1-6
Monocytes 2 % 2 - 10
Basophils 0 % 1-2

Absolute Count
Absolute Neutrophil Count 1.53 * 10^9/L 2.0 - 7.0
(Method: Calculated)
Absolute Lymphocyte Count 1.23 * 10^9/L 1-3
(Method: Calculated)
Absolute Monocyte Count 0.02 * 10^9/L 0.2 - 1.0
(Method: Calculated)
Absolute Eosinophil Count 0.19 * 10^9/L 0.0-0.5
(Method: Calculated)
Absolute Basophils Count 0.05 * 10^9/L 0.02-0.10
(Method: Calculated)
WBC Morphology Leucopenia

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 10 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : WB EDTA* Collected : 12/06/2025, 11:35 AM
Sample ID : 245322922 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:08 PM

HAEMATOLOGY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Platelets
Platelet Count 180 10^3/uL 150 - 450
(Method: Electronic Impedance)
Mean Platelet Volume (MPV) 9 fL 7.2 - 11.7
Platelet Morphology Adequate on smear
PDW 14.6 % 9 - 17
PCT 0.163 % 0.2 - 0.5
(Method: Calculated)
Erythrocyte Sedimentation Rate (ESR) 20 mm/Hour < 10
(Method: Westergren's)

Tests done on Automated Five Part Cell Counter. (WBC, RBC,Platelet count by impedance method, colorimetric method for
Hemoglobin, WBC differential by flow cytometry using laser technology other parameters are calculated). All Abnormal
Haemograms are reviewed confirmed microscopically.

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 11 of 12
Name : MR. ARAVINDA K
Age/Gender : 49 years / Male Ref. Doctor : SELF MEDID : 321323
Sample Type : Naf Plasma Collected : 12/06/2025, 11:35 AM
Sample ID : 245322923 Received : 15/06/2025, 11:39 AM
Client Name : 1KABLR360 Reported : 15/06/2025, 12:21 PM

CLINICAL BIOCHEMISTRY

TEST DESCRIPTION RESULT UNITS REFERENCE RANGES

Glucose - Fasting
Glucose - FBS 222 mg/dL 70 - 109
(Method: Hexokinase)
Interpretation:
Blood glucose test may be used to detect high blood glucose (hyperglycemia) and low blood glucose (hypoglycemia).Screen for diabetes in people who are at risk before signs

and symptoms are apparent; in some cases, there may be no early signs or symptoms of diabetes. Screening can therefore be useful in helping to identify it and allowing for

treatment before the condition worsens or complications arise,Help diagnose diabetes, prediabetes and gestational diabetes,Monitor glucose levels in people diagnosed with

diabetes.

NOTE : Tests marked with the NABL symbol are accredited by NABL under Certificate No. MC-6971.
This sample is processed at HealthMap Diagnostics Pvt Ltd (Bangalore) Lab.

Page 12 of 12